FR2802100B1 - Amylase activee - Google Patents

Amylase activee

Info

Publication number
FR2802100B1
FR2802100B1 FR9915604A FR9915604A FR2802100B1 FR 2802100 B1 FR2802100 B1 FR 2802100B1 FR 9915604 A FR9915604 A FR 9915604A FR 9915604 A FR9915604 A FR 9915604A FR 2802100 B1 FR2802100 B1 FR 2802100B1
Authority
FR
France
Prior art keywords
amylase
activated
activated amylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9915604A
Other languages
English (en)
Other versions
FR2802100A1 (fr
Inventor
Jean Chatillon
Paul Ghislain Coupan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Top Pharm SARL
Original Assignee
Laboratoire Top Pharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Top Pharm SARL filed Critical Laboratoire Top Pharm SARL
Priority to FR9915604A priority Critical patent/FR2802100B1/fr
Priority to PCT/FR2000/003445 priority patent/WO2001041794A2/fr
Priority to AU25251/01A priority patent/AU2525101A/en
Publication of FR2802100A1 publication Critical patent/FR2802100A1/fr
Application granted granted Critical
Publication of FR2802100B1 publication Critical patent/FR2802100B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9915604A 1999-12-10 1999-12-10 Amylase activee Expired - Fee Related FR2802100B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9915604A FR2802100B1 (fr) 1999-12-10 1999-12-10 Amylase activee
PCT/FR2000/003445 WO2001041794A2 (fr) 1999-12-10 2000-12-08 Amylase activee
AU25251/01A AU2525101A (en) 1999-12-10 2000-12-08 Activated amylase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915604A FR2802100B1 (fr) 1999-12-10 1999-12-10 Amylase activee

Publications (2)

Publication Number Publication Date
FR2802100A1 FR2802100A1 (fr) 2001-06-15
FR2802100B1 true FR2802100B1 (fr) 2003-03-21

Family

ID=9553114

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9915604A Expired - Fee Related FR2802100B1 (fr) 1999-12-10 1999-12-10 Amylase activee

Country Status (3)

Country Link
AU (1) AU2525101A (fr)
FR (1) FR2802100B1 (fr)
WO (1) WO2001041794A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908998A1 (fr) * 2006-11-24 2008-05-30 Bao Quoc Ho Nouveau produit enzymatique et son utilisation.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
KR920002161B1 (ko) * 1988-04-27 1992-03-19 조선무약 합자회사 당뇨병 치료제 및 생약 유래 식이성 섬유의 제조방법

Also Published As

Publication number Publication date
FR2802100A1 (fr) 2001-06-15
WO2001041794A3 (fr) 2002-09-12
WO2001041794A2 (fr) 2001-06-14
AU2525101A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
ATE360686T1 (de) Alpha-amylase-varianten
DE122007000064I2 (de) Erythropoietinkonjugate
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50009570D1 (de) Wechselcorrugator
NO20022515D0 (no) Brönnpulsgiver
DE50008613D1 (de) Sicherungsring
DE50006899D1 (de) Antistatikum
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50003660D1 (de) Diacylhydrazinderivate
DE50006013D1 (de) Anschlagpuffer
DE50003259D1 (de) Textilie
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50006759D1 (de) Piperidinalkohole
DE50009208D1 (de) Hydroxyphenylvinylthiazole
DE10082008D2 (de) Ausbeulgerät
DE50006829D1 (de) Benzoylpyridazine
FR2802100B1 (fr) Amylase activee
DE50003283D1 (de) Exzenterspannzwinge
ATE440824T1 (de) Nitro-sulfobenzamide
ATA107599A (de) Heizwasserbereiter

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: LABORATOIRE TOP-PHARMA, FR

Effective date: 20120118

TP Transmission of property

Owner name: LABORATOIRE TOP-PHARMA, FR

Effective date: 20120118

PLFP Fee payment

Year of fee payment: 17

ST Notification of lapse

Effective date: 20170831